The authors conclude that prolonged use and higher doses of GLP-1-Ra were associated with a reduced risk of hospitalization for ischemic stroke among Asian patients with T2DM who did not have established atherosclerotic CVD [42]. The gene discussed is GCG; the disease is ischemic stroke.